IP Library Granted Patent US 10,836,660
Granted Patent B2
US 10,836,660 · App. 16/501,533 · Granted Nov 17, 2020

Method and composition for use in the cyclic process for the efficient generation of chlorine dioxide in dilute solutions

Inventor: Roy W. Martin (Downers Grove, IL)
Assignee: Truox, Inc.
C02F1/766C02F1/008C02F1/76G01N33/182C02F2103/42C02F2209/29C02F2303/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,836,660
App. No.
16/501,533
Granted
Nov 17, 2020
Kind
B2
Abstract

This invention relates to a method for monitoring and controlling the relative concentration of bromide ion used in the cyclic process for enhanced sanitation and oxidation of aqueous systems at aquatic facilities.

Claims (33)

1. A method for determining the relative bromide ion concentration in an aqueous system of an aquatic facility using a cyclic process, the method comprising:

the cyclic process comprising activating bromide ions with an oxidant to produce free bromine, the free bromine oxidizes chlorite ions to produce chlorine dioxide, and reducing at least some free bromine back to bromide ions,

applying a composition comprising a bromide donor and a tracer; the composition is applied to the aqueous system to maintain a bromide ion concentration ranging from 2 ppm to 5000 ppm;

measuring the tracer to determine the relative concentration of bromide ion, and

maintaining the bromide ion concentration by adding additional composition to ensure the cyclic process and subsequent microbiological efficacy is achieved.

2. The method in accordance with claim 1 , wherein the tracer comprises a molybdate donor.

3. The method in accordance with claim 2 , wherein the molybdate donor comprises sodium molybdate.

4. The method in accordance with claim 2 , wherein the concentration of molybdate measured in the aqueous system is sustained between 0.02 ppm to 2.0 ppm.

5. The method in accordance with claim 4 , wherein the concentration of molybdate measured in the aqueous system is sustained between 0.05 ppm to 1.0 ppm.

6. The method in accordance with claim 5 , wherein the concentration of molybdate measured in the aqueous system is sustained between 0.10 ppm to 0.80 ppm.

7. The method in accordance with claim 1 , wherein the bromide ion concentration ranges from 4 ppm to 500 ppm.

8. The method in accordance with claim 7 , wherein the bromide ion concentration ranges from 5 ppm to 100 ppm.

9. The method of claim 1 , the composition further comprising dialkylhydantoin.

10. The composition in accordance with claim 9 , wherein the dialkylhydantoin comprises 5,5-dimethylhydantoin.

11. The composition in accordance with claim 9 , wherein the dialkylhydantoin comprises 5-ethyl-5-methylhydantoin.

12. The method in accordance with claim 1 , wherein the microbiological efficacy comprises achieving at least a 3-log inactivation of Cryptosporidium.

13. The method in accordance with claim 12 , wherein the microbiological efficacy comprises achieving at least a 4-log inactivation of Cryptosporidium.

14. The method in accordance with claim 1 , wherein the microbiological efficacy comprises maintaining the aqueous system free of coliform bacteria.

15. A method for determining the relative bromide ion concentration in an aqueous system of an aquatic facility using free bromine resulting from the reaction between an oxidizing activator and bromide ions, the method comprising:

applying a composition comprising a bromide donor and a tracer; the composition is applied to the aqueous system to maintain a bromide ion concentration ranging from 2 ppm to 5000 ppm;

measuring the tracer to determine the relative concentration of bromide ions, and

maintaining the bromide ion concentration by adding additional composition to ensure sufficient free bromine and subsequent microbiological efficacy is achieved.

16. The method in accordance with claim 15 , wherein the tracer is molybdate donor.

17. The method in accordance with claim 16 , wherein the molybdate donor comprises sodium molybdate.

18. The method in accordance with claim 16 , wherein the concentration of molybdate measured in the aqueous system is sustained between 0.02 ppm to 2.0 ppm.

19. The method in accordance with claim 18 , wherein the concentration of molybdate measured in the aqueous system is sustained between 0.05 ppm to 1.0 ppm.

20. The method in accordance with claim 19 , wherein the concentration of molybdate measured in the aqueous system is sustained between 0.10 ppm to 0.80 ppm.

21. The method in accordance with claim 15 , wherein the bromide ion concentration ranges from 4 ppm to 500 ppm.

22. The method in accordance with claim 21 , wherein the bromide ion concentration ranges from 5 ppm to 100 ppm.

23. The method of claim 15 , the composition further comprising dialkylhydantoin.

24. The method in accordance with claim 23 , wherein the dialkylhydantoin comprises 5,5-dimethylhydantoin.

25. The method in accordance with claim 23 , wherein the dialkylhydantoin comprises 5-ethyl-5-methylhydantoin.

26. The method in accordance with claim 15 , wherein the microbiological efficacy comprises maintaining the aqueous system free of coliform bacteria.

Continuity (2)
Continuation In Part 16350668 · Dec 18, 2018
Related Publication 20200189944A1 · Jun 18, 2020